Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2005

01-06-2005 | Book report

Morrow M, Jordan VC: Managing Breast Cancer Risk. 1st Edition. Hamilton, Ontario: BC Decker Inc

2003. 302 pp. ISBN 1-55009-260-X

Authors: Kai Ren Ong, Anthony Howell

Published in: Breast Cancer Research | Issue 3/2005

Login to get access

Excerpt

'Prevention is better than healing because it saves the labour of being sick' …
Metadata
Title
Morrow M, Jordan VC: Managing Breast Cancer Risk. 1st Edition. Hamilton, Ontario: BC Decker Inc
2003. 302 pp. ISBN 1-55009-260-X
Authors
Kai Ren Ong
Anthony Howell
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1024

Other articles of this Issue 3/2005

Breast Cancer Research 3/2005 Go to the issue

Research article

c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Commentary

Breast cancer and childhood anthropometry: emerging hypotheses?

Commentary

Accelerated partial breast irradiation: the case for current use

Review

Endocrinology and hormone therapy in breast cancer: Selective oestrogen receptor modulators and downregulators for breast cancer – have they lost their way?

Review

Mammary stem cells, self-renewal pathways, and carcinogenesis

Research article

Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits